Cargando…

Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common form of dementia. The development of assay technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers, such as amyloid and total Tau protein, are among the most promising diagnostic methods due to their low cost, low risk,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shieh-Yueh, Chiu, Ming-Jang, Chen, Ta-Fu, Horng, Herng-Er
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520821/ https://www.ncbi.nlm.nih.gov/pubmed/28733955 http://dx.doi.org/10.1007/s40120-017-0075-7

Ejemplares similares

Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction
por: Liu, Huei-Chun, et al.
Publicado: (2021)

Use of immunomagnetic reduction for C-reactive protein assay in clinical samples
por: Chang, Chien-Hsi, et al.
Publicado: (2012)

Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology
por: Liu, Huei-Chun, et al.
Publicado: (2020)

Long-Term Storage Effects on Stability of Aβ(1–40), Aβ(1–42), and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays
por: Chiu, Ming-Jang, et al.
Publicado: (2019)

Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction
por: Chen, Hsin-Hsien, et al.
Publicado: (2022)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
por: Lin, Chin-Hsien, et al.
Publicado: (2018)

Immunomagnetic Reduction Detects Plasma Aβ(1–42) Levels as a Potential Dominant Indicator Predicting Cognitive Decline
por: Yang, Shieh-Yueh, et al.
Publicado: (2020)

Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
por: Yang, Shieh-Yueh, et al.
Publicado: (2016)

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
por: Chiu, Pai-Yi, et al.
Publicado: (2022)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Non-invasive screening for early Alzheimer’s disease diagnosis by a sensitively immunomagnetic biosensor
por: Li, Shan-Shan, et al.
Publicado: (2016)

Plasma Tau Levels in Cognitively Normal Middle-Aged and Older Adults
por: Chiu, Ming-Jang, et al.
Publicado: (2017)

Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology
por: Lue, Lih-Fen, et al.
Publicado: (2019)

Applications of Immunomagnetic Reduction Technology as a Biosensor in Therapeutic Evaluation of Chinese Herbal Medicine in Tauopathy Alleviation of an AD Drosophila Model
por: Su, Ming-Tsan, et al.
Publicado: (2022)

The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Ling-Yun, et al.
Publicado: (2018)

Immunomagnetic nanoparticle-based assays for detection of biomarkers
por: Park, Hoyoung, et al.
Publicado: (2013)

Synergistic Association between Plasma Aβ(1–42) and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
por: Chiu, Ming-Jang, et al.
Publicado: (2021)

Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome
por: Wu, Chung-Hsin, et al.
Publicado: (2023)

A Novel Detection Platform for Shrimp White Spot Syndrome Virus Using an ICP11-Dependent Immunomagnetic Reduction (IMR) Assay
por: Liu, Bing-Hsien, et al.
Publicado: (2015)

Assessment of High Risk for Alzheimer’s Disease Using Plasma Biomarkers in Subjects with Normal Cognition in Taiwan: A Preliminary Study
por: Hu, Chaur-Jong, et al.
Publicado: (2021)

Validation of Assaying Carcinoembryonic Antigen in Human Serum by Using Immunomagnetic Reduction
por: Wei, Po-Li, et al.
Publicado: (2018)

Promise and Challenge: The Lens Model as a Biomarker for Early Diagnosis of Alzheimer's Disease
por: Tian, Tian, et al.
Publicado: (2014)

Diagnosis of canine leptospirosis using an immunomagnetic separation-PCR method
por: Monte, Leonardo Garcia, et al.
Publicado: (2012)

Eight-Channel AC Magnetosusceptometer of Magnetic Nanoparticles for High-Throughput and Ultra-High-Sensitivity Immunoassay
por: Chieh, Jen-Jie, et al.
Publicado: (2018)

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
por: Chang, Chun-Wei, et al.
Publicado: (2020)

Quantitative analysis of total β-subunit of human chorionic gonadotropin concentration in urine by immunomagnetic reduction to assist in the diagnosis of ectopic pregnancy
por: Chen, Chen-Yu, et al.
Publicado: (2015)

Evidence of plasma biomarkers indicating high risk of dementia in cognitively normal subjects
por: Pai, Ming-Chyi, et al.
Publicado: (2022)

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
por: Lue, Lih-Fen, et al.
Publicado: (2017)

Biomarkers for Alzheimer’s Disease Early Diagnosis
por: Ausó, Eva, et al.
Publicado: (2020)

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease
por: Stevenson-Hoare, Joshua, et al.
Publicado: (2022)

FACS and immunomagnetic isolation of early erythroid progenitor cells from mouse fetal liver
por: Braun, Tatum W., et al.
Publicado: (2021)

Influence of immunomagnetic enrichment on gene expression of tumor cells
por: Woelfle, Ute, et al.
Publicado: (2005)

Discriminating Hepatocellular Carcinoma in Rats Using a High-T(c) SQUID Detected Nuclear Resonance Spectrometer in a Magnetic Shielding Box
por: Huang, Kai-Wen, et al.
Publicado: (2012)

Correction: Discriminating Hepatocellular Carcinoma in Rats Using a High-T(c) SQUID Detected Nuclear Resonance Spectrometer in a Magnetic Shielding Box
por: Huang, Kai-Wen, et al.
Publicado: (2014)

CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease
por: Teuber-Hanselmann, Sarah, et al.
Publicado: (2020)

Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand
por: Chiu, Chen-Tzu, et al.
Publicado: (2020)

Evaluation of Immunomagnetic Separation for the Detection of Salmonella in Surface Waters by Polymerase Chain Reaction
por: Hsu, Chao-Yu, et al.
Publicado: (2014)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease
por: Ma, Suk Ling, et al.
Publicado: (2011)

Predictive Periodontitis: The Most Promising Salivary Biomarkers for Early Diagnosis of Periodontitis
por: Cafiero, Carlo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ferpi782b6v09nhfdj420606vd